IGF1 and hepatocellular carcinoma: Moreover, we previously reported that platelet-associated IGF1 antagonized Regorafenib-mediated growth, migration and invasion inhibition, as well as the drug-mediated induction of apoptosis in HCC cells in vitro [15], suggesting common escape mechanisms for both Sorafenib and Regorafenib.